Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 1652-1657, 2007. First published June 28, 2007; 10.1373/clinchem.2006.083923
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 083923.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.083923v1
53/9/1652    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuman, R. B.
Right arrow Articles by Dudley, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuman, R. B.
Right arrow Articles by Dudley, S. C., Jr
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2007;53:1652-1657.)
© 2007 American Association for Clinical Chemistry, Inc.

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation

Robert B. Neuman1,2, Heather L. Bloom1,2,2, Irfan Shukrullah1,2, Lyndsey A. Darrow3, David Kleinbaum3, Dean P. Jones4 and Samuel C. Dudley, Jr1,2,a

1 Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
2 Division of Cardiology, Atlanta Veterans Affairs Medical Center, Atlanta, GA.
3 Rollins School of Public Health, Emory University, Atlanta, GA.
4 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA.

aAddress correspondence to this author at: Division of Cardiology, Emory University/VAMC, 1670 Clairmont Rd. (111B), Decatur, GA 30033. Fax 404-329-2211; e-mail sdudley{at}emory.edu.

Background: Atrial fibrillation (AF) has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. We compared serum markers of oxidation and associated inflammation in individuals with or without AF.

Methods: Serum markers of oxidative stress and inflammation were compared in a cross-sectional, case-control design study of 40 male individuals, with or without persistent or permanent AF, who were matched for age, sex, diabetes, and smoking status, known confounding variables for the measurement of oxidative stress. We used derivatives of reactive oxidative metabolites (DROMs) and ratios of oxidized to reduced glutathione (Eh GSH) and cysteine (Eh CySH) to quantify oxidative stress. We also measured inflammatory markers, including high-sensitivity C-reactive protein, interleukins 1ß and 6, and tumor necrosis factor {alpha}.

Results: Univariate, conditional logistical regression analysis showed that oxidative stress but not inflammatory markers were statistically associated with AF (P <0.05). The increase in the odds ratios for AF for Eh GSH, Eh CySH, and DROMs were 6.1 (95% CI, 1.3–28.3; P = 0.02), 13.6 (95% CI, 2.5–74.1; P = 0.01), and 15.9 (95% CI, 1.7–153.9; P = 0.02), respectively. There was a stronger correlation between Eh GSH and Eh CySH (r = 0.66) than between Eh GSH and DROMs (r = 0.41). In multivariate analysis corrected for statins and other AF risk factors differing between the groups, the association of AF and oxidative stress remained significant.

Conclusions: These data suggest that oxidative stress markers may have predictive value in AF management.




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Physiol. Cell Physiol.Home page
D. P. Jones
Radical-free biology of oxidative stress
Am J Physiol Cell Physiol, October 1, 2008; 295(4): C849 - C868.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
J. Sanchez-Quinones, F. Marin, V. Roldan, and G.Y.H. Lip
The impact of statin use on atrial fibrillation
QJM, August 24, 2008; (2008) hcn101v1.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
W. C. De Mello
Metallothionein Reverses the Harmful Effects of Angiotensin II on the Diabetic Heart
J. Am. Coll. Cardiol., August 19, 2008; 52(8): 667 - 669.
[Full Text] [PDF]

Home page
 Circ Arrhythmia ElectrophysiolHome page
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 62 - 73.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study
Eur. Heart J., March 1, 2008; 29(5): 625 - 631.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.